INTRODUCTION: To evaluate the impact of specialized neurocritical care on the population admitted to a neurovascular center and on the outcome of patients with severe aneurysmal subarachnoid hemorrhage (aSAH). METHODS: After exclusion of patients treated with endovascular techniques, between 1999 and 2003, 198 patients with aSAH treated with early aneurysm clipping were analysed. In 1999, a new standardized protocol for intensive care treatment was established in the Department of Neurosurgery, University Hospital Zurich. The results were compared to the earlier time period (1993-1994) immediately after introduction of early aneurysm clipping. RESULTS: Out of 198 patients with aSAH, 90 patients (45.5%) suffered from mild aSAH World Federation of Neurosurgical Societies (WFNS) grade 1 and 2, 41 (27.3%) from aSAH WFNS grade 3, 36 (18.2%) from grade 4, and 57 (28.8%) from grade 5. From 1999 to 2003, significantly more patients with severe aSAH WFNS grade 4 and 5 underwent (further) treatment (93 out of 198 patients; 47.0%) compared to the former time-period after introduction of early surgery (23 out of 150 patients; 15.3%) (p < 0.0001). In the early series, 10 out of 23 patients (43.5%) with WFNS 4 recovered with good outcome Glasgow Outcome Score 4 and 5, whereas in the later series 23 out of 36 (63.9%) with WFNS grade 4 survived in a good functional state. Before 1999, all patients with WFNS grade 5 died or survived in a vegetative state. From 1999 to 2003, 20 out of 57 patients (35.1%) with aSAH WFNS grade 5 survived with good outcome. CONCLUSIONS: The availability of extended specialized neurocritical care seems to induce a change within the patient population towards a higher severity grade. Patients with highgrade aSAH might benefit most from highly specialized neurocritical care treatment.
INTRODUCTION: To evaluate the impact of specialized neurocritical care on the population admitted to a neurovascular center and on the outcome of patients with severe aneurysmal subarachnoid hemorrhage (aSAH). METHODS: After exclusion of patients treated with endovascular techniques, between 1999 and 2003, 198 patients with aSAH treated with early aneurysm clipping were analysed. In 1999, a new standardized protocol for intensive care treatment was established in the Department of Neurosurgery, University Hospital Zurich. The results were compared to the earlier time period (1993-1994) immediately after introduction of early aneurysm clipping. RESULTS: Out of 198 patients with aSAH, 90 patients (45.5%) suffered from mild aSAH World Federation of Neurosurgical Societies (WFNS) grade 1 and 2, 41 (27.3%) from aSAH WFNS grade 3, 36 (18.2%) from grade 4, and 57 (28.8%) from grade 5. From 1999 to 2003, significantly more patients with severe aSAH WFNS grade 4 and 5 underwent (further) treatment (93 out of 198 patients; 47.0%) compared to the former time-period after introduction of early surgery (23 out of 150 patients; 15.3%) (p < 0.0001). In the early series, 10 out of 23 patients (43.5%) with WFNS 4 recovered with good outcome Glasgow Outcome Score 4 and 5, whereas in the later series 23 out of 36 (63.9%) with WFNS grade 4 survived in a good functional state. Before 1999, all patients with WFNS grade 5 died or survived in a vegetative state. From 1999 to 2003, 20 out of 57 patients (35.1%) with aSAH WFNS grade 5 survived with good outcome. CONCLUSIONS: The availability of extended specialized neurocritical care seems to induce a change within the patient population towards a higher severity grade. Patients with highgrade aSAH might benefit most from highly specialized neurocritical care treatment.
Authors: Anthony L D'Ambrosio; Michael E Sughrue; Joshua G Yorgason; J D Mocco; Kurt T Kreiter; Stephan A Mayer; Guy M McKhann; E Sander Connolly Journal: Neurosurgery Date: 2005 Impact factor: 4.654
Authors: Andrew M Naidech; Kurt T Kreiter; Nazli Janjua; Noeleen Ostapkovich; Augusto Parra; Christopher Commichau; E Sander Connolly; Stephan A Mayer; Brian-Fred M Fitzsimmons Journal: Stroke Date: 2005-01-20 Impact factor: 7.914
Authors: Josef M Lang; Jürgen Meixensberger; Andreas W Unterberg; Andreas Tecklenburg; Joachim K Krauss Journal: Langenbecks Arch Surg Date: 2011-03-08 Impact factor: 3.445
Authors: Jan Claassen; Angela Velazquez; Emma Meyers; Jens Witsch; M Cristina Falo; Soojin Park; Sachin Agarwal; J Michael Schmidt; Nicholas D Schiff; Jacobo D Sitt; Lionel Naccache; E Sander Connolly; Hans-Peter Frey Journal: Ann Neurol Date: 2016-08-16 Impact factor: 10.422
Authors: Carl Muroi; Johanna B Lemb; Michael Hugelshofer; Martin Seule; David Bellut; Emanuela Keller Journal: Neurocrit Care Date: 2014-08 Impact factor: 3.210
Authors: Joseph D Burns; Deborah M Green; Helena Lau; Michael Winter; Feliks Koyfman; Christina M DeFusco; James W Holsapple; Carlos S Kase Journal: Neurocrit Care Date: 2013-06 Impact factor: 3.210
Authors: Hannah C Glass; Sonia L Bonifacio; Susan Peloquin; Thomas Shimotake; Sally Sehring; Yao Sun; Joseph Sullivan; Elizabeth Rogers; A James Barkovich; David Rowitch; Donna M Ferriero Journal: Neurocrit Care Date: 2010-06 Impact factor: 3.210
Authors: Shaurya Taran; Vatsal Trivedi; Jeffrey M Singh; Shane W English; Victoria A McCredie Journal: Neurocrit Care Date: 2020-06 Impact factor: 3.210